CMC Analytical Services for Biologics, ADCs, and CGT
Product Description
Crystal Pharmatech
-
Country/Region:China
-
On CPHI since:2024
-
Certificates:2
Crystal Pharmatech
-
Country/Region:China
-
On CPHI since:2024
-
Certificates:2
More Products from Crystal Pharmatech (4)
-
Product Bioanalysis and Biomarker Services
Crystal Bio Solutions provides end-to-end bioanalytical and biomarker support for biologics, ADCs, and CGT. Our GLP compliant laboratories and senior scientists design, develop, qualify, and validate assays that stand up to FDA, EMA, and NMPA review. We cover immunogenicity and neutrality risk, PK and PD, ... -
Product Integrated Formulation Development, GMP Manufacturing & Global Delivery
Crystal Pharmatech provides end-to-end oral solid dose development, injectable, lipid-based formulation development, and clinical manufacturing under one roof—seamlessly uniting enabling technologies for insoluble drugs (spray-dried ASDs, hot-melt extrusion, lipid and nano platforms) with conventional and ... -
Product Integrated Small Molecule CRO Platforms
This service unifies material-sparing FAST analytics, solid-state research, lab-scale crystallization development, and pre-formulation into a single early-development track that turns scarce API into decision-ready insight and scale-transferable processes. We start with focused solid-state testing to revea... -
Product Mol2Med™ Developability Assessment
Mol2Med is a modular, material-sparing path that integrates experimental testing, PBPK modeling, and form selection from API profiling through preclinical formulation design. Selected for first-time-right decisions on aggressive timelines, it can deliver go/no-go answers in ≤4 weeks with ≥500 mg API while ...
Crystal Pharmatech resources (2)
-
Brochure Crystal Pharmatech Company Overview
Small Molecule CRO/CDMO Business Unit Overview of Crystal Pharmatech -
Brochure Crystal Bio Solutions Company Overview
Crystal Bio Solutions, a Crystal Pharmatech subsidiary: US CRO for GLP/GCLP bioanalysis, biomarkers, clinical research, regulatory support, and CMC analytics。